Comments
Loading...
Avid Bioservices (CDMO) Forecast
NewsEarningsAvid Bioservices (CDMO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAvid Bioservices (NASDAQ:CDMO) Stock Quotes, Forecast and News Summary
Avid Bioservices Stock (NASDAQ: CDMO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Avid Bioservices (CDMO) stock?
You can purchase shares of Avid Bioservices (NASDAQ:CDMO) through any online brokerage.
Who are Avid Bioservices (CDMO) competitors?
Other companies in Avid Bioservices’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL), Altimmune (NASDAQ:ALT) and Immatics (NASDAQ:IMTX).
What is the forecast, or price target, for Avid Bioservices (CDMO) stock?
Avid Bioservices has a consensus price target of $13.63.
What is the current price for Avid Bioservices (CDMO)?
The stock price for Avid Bioservices (NASDAQ: CDMO) is $12 last updated November 14, 2024 at 3:00 PM EST.
Does Avid Bioservices (CDMO) pay a dividend?
There are no upcoming dividends for Avid Bioservices.
When is Avid Bioservices (NASDAQ:CDMO) reporting earnings?
Avid Bioservices’s Q2 earnings are confirmed for Thursday, December 5, 2024.
Is Avid Bioservices (CDMO) going to split?
There is no upcoming split for Avid Bioservices.
What sector and industry does Avid Bioservices (CDMO) operate in?
Avid Bioservices is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.